A year after Vertex’s big launch, pain drug research faces a pivotal moment

🇺🇸 BioPharma Dive (US) —

AI Summary

Vertex's pain drug research reaches a critical point, one year after the big launch of their new medication. As excitement fluctuates, the focus is on whether other pain drugs can replicate this initial success.

Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?

Health pain drug Vertex research healthcare pharmaceuticals

Read original source →